Indications and early results of sildenafil (Viagra) in erectile dysfunction - an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

By Virag R.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1073-1077

Elsevier

Access to resources Recommend Favorite

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate - an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

By Zelefsky M.J.   Mckee A.B.   Lee H.   Leibel S.A.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 775-778

Elsevier

Access to resources Recommend Favorite

IL-8-Stimulated Expression of Urokinase-Type Plasminogen Activator in Human Skin and Human Epidermal Cells

By Han Y-P.   Hughes M.W.   Nien Y-D.   Garner W.L.  

Journal of Surgical Research, Vol. 106, Iss. 2, 2002-08 ,pp. : 328-334

Academic Press

Access to resources Recommend Favorite

Expression of Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma and Postoperative Outcomes

By Funagayama Mayumi  

World Journal of Surgery, Vol. 34, Iss. 7, 2010-07 ,pp. : 1563-1571

Springer Publishing Company

Access to resources Recommend Favorite

Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats

By Sadakane Chiharu   Kase Yoshio   Koseki Junichi   Hasegawa Yoshihiro   Shindo Shoichiro   Maruyama Hirobumi   Takeda Shuichi   Takeda Hiroshi   Hattori Tomohisa  

Clinical and Experimental Nephrology, Vol. 15, Iss. 1, 2011-02 ,pp. : 14-24

Springer Publishing Company

Access to resources Recommend Favorite